Vivos Therapeutics, Inc.
VVOS
$2.57
$0.000.00%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 6.31M | 6.90M | 2.61M | 1.64M | 988.00K |
Total Receivables | 454.00K | 395.00K | 525.00K | 202.00K | 228.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 634.00K | 554.00K | 475.00K | 616.00K | 769.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 7.40M | 7.85M | 3.61M | 2.46M | 1.99M |
|
|||||
Total Current Assets | 7.40M | 7.85M | 3.61M | 2.46M | 1.99M |
Net Property, Plant & Equipment | 4.45M | 4.48M | 4.63M | 4.70M | 4.75M |
Long-term Investments | 2.84M | 2.84M | 2.84M | 2.84M | 2.84M |
Goodwill | 2.84M | 2.84M | 2.84M | 2.84M | 2.84M |
Total Other Intangibles | 383.00K | 395.00K | 408.00K | 420.00K | 433.00K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 276.00K | 276.00K | 308.00K | 307.00K | 307.00K |
Total Assets | 15.35M | 15.84M | 11.80M | 10.73M | 10.32M |
|
|||||
Total Accounts Payable | 1.08M | 2.03M | 2.50M | 2.15M | 1.53M |
Total Accrued Expenses | 2.05M | 2.19M | 2.47M | 2.33M | 1.92M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 485.00K | 484.00K | 483.00K | 474.00K | 460.00K |
Total Finance Division Other Current Liabilities | 1.51M | 1.95M | 2.62M | 2.34M | 3.26M |
Total Other Current Liabilities | 1.51M | 1.95M | 2.62M | 2.34M | 3.26M |
Total Current Liabilities | 5.13M | 6.64M | 8.07M | 7.29M | 7.17M |
|
|||||
Total Current Liabilities | 5.13M | 6.64M | 8.07M | 7.29M | 7.17M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 1.16M | 1.28M | 1.40M | 1.52M | 1.64M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 1.40M | 1.57M | 1.75M | 1.51M | 1.46M |
Total Liabilities | 7.68M | 9.50M | 11.22M | 10.32M | 10.27M |
|
|||||
Common Stock & APIC | 109.03M | 105.09M | 97.40M | 93.46M | 88.84M |
Retained Earnings | -101.36M | -98.74M | -96.81M | -93.05M | -88.79M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 7.67M | 6.35M | 582.00K | 411.00K | 46.00K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 7.67M | 6.35M | 582.00K | 411.00K | 46.00K |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 7.67M | 6.35M | 582.00K | 411.00K | 46.00K |
|